Get the Prostate Cancer Patient Guide as a digital download or free mailed copy.

Click here.

Session 1: Novel Clinical Trial Updates

Session 1: Novel Clinical Trial Updates
29th Annual PCF Scientific Retreat: October 27, 2022 | 1:05 PM – 2:25 PM

Moderator: Jake Vinson, MHA
The Prostate Cancer Clinical Trials Consortium

Targeting a Tumor-Specific CD46 Epitope in Metastatic Castration Resistant Prostate Cancer
Rahul Aggarwal, MD
University of California, San Francisco

Targeting Myeloid Chemotaxis via CXCR2 Blockade as a Therapeutic Strategy in Advanced Prostate Cancer
Christina Guo, MD
Institute for Cancer Research; Royal Marsden Hospital, UK

Biomarker Results from Targeting TROP2 with Sacituzumab Govitecan in mCRPC
Joshua Lang, MD
University of Wisconsin

TRITON3: A Phase 3 Study of Rucaparib vs. Physician’s Choice of Therapy in mCRPC associated with HRD
Alan Bryce, MD
Mayo Clinic